IPOS 2022: WORLD CONGRESS                                  REIMAGINING PSYCHOSOCIAL ONCOLOGY: EMBRACING VOICES FROM AROUND THE WORLD

TORONTO, CANADA  •  AUGUST 29 - SEPTEMBER 1, 2022





PROGRAM 

IPOS 2022 Speakers

KEYNOTE SPEAKERS

ANTHONY P. BOSSIS

Ph.D


Use of Psilocybin for the Treatment of Psychosocial Distress in Palliative Care and at the End-of-Life

Anthony P. Bossis, Ph.D. is a clinical psychologist and clinical assistant professor of psychiatry at NYU Grossman School of Medicine and NYU Center for Psychedelic Medicine conducting FDA-approved research with the psychedelic compound psilocybin since 2006. Dr. Bossis was director of palliative care research and co-principal investigator on the landmark 2016 clinical trial demonstrating a significant reduction in emotional distress from a single psilocybin session in persons with cancer, specifically, a rapid decrease in depression, anxiety, hopelessness, and demoralization along with improvements in spiritual well-being and quality of life. He is study director and lead therapist on an FDA-approved clinical trial investigating a psilocybin-generated mystical experience upon religious leaders. Dr. Bossis is a training supervisor of psychotherapy at NYU-Bellevue Hospital and co-founder of the Bellevue Hospital Palliative Care Service. He is on the editorial board of the Journal of Humanistic Psychology and a guest editor (with Charles Grob, M.D.) for the journal’s Special Series on Psychedelics. His primary psychedelic research interests are the treatment of end-of-life existential distress and the study of consciousness, meaning, and spirituality. He maintains a private psychotherapy and consulting practice in NYC.


ASSOCIATE PROFESSOR NICOLE RANKIN



Embracing health equity: opportunities to transform research translation in psycho-oncology

Associate Professor Nicole Rankin is an implementation scientist in the Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Australia. Nicole is Director of the Implementation Science Program at Sydney Health Partners, which is a collaboration between the University of Sydney and four Local Health Districts, whose goal is to demonstrate how evidence-based interventions can be successfully implemented and scaled-up in diverse and complex health systems. 

A/Prof Rankin’s research focuses on the science of research translation, including how evidence can be more rapidly translated into clinical practice, with a significant focus on lung cancer. Her research portfolio extends from lung cancer screening, early detection, and management through to multidisciplinary care, palliative care and survivorship. Her interests include psychosocial care and how health services can better meet the needs of people diagnosed with cancer and other chronic conditions. Her expertise is applied across a portfolio of research projects, in leading capacity building initiatives such as masterclasses, workshops and conferences, as well as mentoring clinician-researchers and doctoral candidates to develop their careers in research translation.